Specialty Neuroscience
-
Featured
Understanding COVID-19's Neurological Effects
Massachusetts General Hospital investigators are using unprecedented collaboration and frontline experience to better understand the neurological effects of SARS-CoV-2 infection.
-
Teaching Resiliency to Help Health Care Professionals Cope: Q&A with Daphne J. Holt, MD, PhD
In this Q&A, Daphne J. Holt, MD, PhD, teaches skills for dealing with the overwhelming stress on health care workers during the pandemic and discusses how learning resiliency through online training can help them manage their mental health during this stressful time.
-
Functional MRI Marker Can Diagnose Migraine Without Aura
Massachusetts General Hospital researchers have identified and validated a distinctive pattern of abnormal brain connections on functional MRI that discriminates between patients with and without migraine.
-
White Matter Abnormality Underlies Emotional Dysregulation in Children
Weakened microstructure along the cingulum–callosal neurocircuitry in white matter may represent a biomarker that identifies children at risk of developing mood disorders.
-
Use of Prion Protein Biomarker in Prion Disease Therapy Clinical Trials
The level of prion protein in CSF is a suitable biomarker for primary prevention trials of drugs for genetic prion disease.
-
New Tool Identifies Risk of Neurotoxicity After CAR T-cell Therapy
A new scoring system identifies patients at higher risk of neurotoxicity after CAR T-cell therapy, which may prevent the need for routine prolonged hospitalization for observation.
Neuroscience contributors
-
Aman B. Patel, MD
Director of Cerebrovascular and Endovascular Neurosurgery, Co-Director of the Neuroendovascular Program
Recent Article
Stroke-Risk, COVID-19 and When to Seek Emergency Care
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Gene Fusions Detected in Plasma of Glioblastoma Patients, Suggesting New Approach to Liquid Biopsy
-
Ghazaleh Sadri-Vakili, MS, PhD
Assistant in Neuroscience, Massachusetts General Hospital, Assistant Professor of Neurology, Harvard Medical School
Recent Article
Cromolyn Sodium Provides Neuroprotection in Animal Model of ALS
-
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine, Massachusetts General Hospital
Recent Article
Portable Imaging Test Shows Promise for Detection of Cannabis Intoxication
-
Jordan W. Smoller, MD, ScD
Associate Chief for Research, Department of Psychiatry, Massachusetts General Hospital, Director, Psychiatric and Neurodevelopmental Genetics Unit, Professor of Psychiatry at Harvard Medical School and Professor in the Department of Epidemiology at the Harvard School of Public Health
Recent Article
Multiple Common Genetic Loci Underlie Eight Psychiatric Disorders
-
Maurizio Fava, MD
Psychiatrist-In-Chief; Director, Division of Clinical Research of the MGH Research Institute, Executive Director, Clinical Trials Network and Institute (CTNI), Massachusetts General Hospital, Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School
Recent Article
Improvement Needed in Genetic Test–Guided Treatment of Major Depressive Disorder
-
Merit Ester Cudkowicz, MD, MSc
Chief, Neurology Service, Director of the Sean M. Healey & AMG Center for ALS at Mass General, Director of Neurological Clinical Research Institute and the Jilieane Dorn Professor of Neurology, Harvard Medical School
Recent Article
Tofersen for ALS Clears Phase 1/2 Trial, Now in Phase 3
-
Natalia S. Rost, MD, MPH, FAAN
Chief of Stroke Division, Department of Neurology, Massachusetts General Hospital, Professor of Neurology, Harvard Medical School
Recent Article
MGH Research Scholars Respond to COVID-19
-
Rudolph E. Tanzi, PhD
Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School, Vice-Chair, Massachusetts General Hospital Neurology Department, Co-Director of the McCance Center for Brain Health, Massachusetts General Hospital
Recent Article
The Innate Immune Protection Hypothesis of Alzheimer's Disease
-
Timothy Wilens, MD
Chief, Division of Child and Adolescent Psychiatry, Massachusetts General Hospital, Co-director, Center for Addiction Medicine, Director, Substance Abuse Services in Pediatric Psychopharmacology
Recent Article
Treatment for Substance Use Disorder Reduces Risk of Overdose in Young Adults
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Endonasal Surgery Using High-Speed Drill Puts Health Care Team at Risk of COVID-19
-
Ziv Williams, MD
Associate Professor in Neurosurgery
Recent Article
Spine Surgeon Specialty Does Not Influence Short-term Outcomes of Percutaneous Kyphoplasty
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
